The Role of Hemoglobin and Anemia in Dementia Risk and Prevention
Overview
Anemia, affecting 25% of the global population, is associated with a significantly increased risk of developing dementia. Population-based data reveal a 66% relative increase in dementia risk among anemic individuals, with risk rising notably below hemoglobin levels of 14 g/dL.
Background
Dementia incidence is rising worldwide, necessitating identification of modifiable risk factors for prevention. Anemia is prevalent globally, especially in regions with expected steep increases in dementia cases. Hemoglobin, the oxygen-carrying protein, may influence neurodegenerative processes through impaired cerebral oxygenation and other mechanisms. Recent studies have linked anemia not only to dementia risk but also to elevated plasma biomarkers indicative of neurodegeneration.
Data Highlights
Parameter
Value
Study population (SNAC-K)
2282 participants
Mean follow-up duration
9.4 years
Dementia diagnoses during follow-up
362 participants
Relative increase in dementia risk with anemia
66%
Hemoglobin threshold for increased risk
Approximately 14 g/dL
Dementia risk increase with anemia plus elevated plasma markers
3- to 4-fold
Key Findings
Anemia is linked to a 66% higher relative risk of developing dementia over nearly a decade of follow-up.
The relationship between hemoglobin levels and dementia risk follows a J-shaped curve, with risk increasing below ~14 g/dL.
Anemia correlates with elevated plasma biomarkers of neurodegeneration, including phosphorylated tau 217, neurofilament light chain, and glial fibrillary acidic protein.
Combined presence of anemia and elevated neurodegenerative biomarkers increases dementia risk 3- to 4-fold.
Both macrocytic and microcytic anemia types are associated with higher dementia risk compared to normocytic anemia.
Potential mechanisms include impaired cerebral oxygen delivery and disturbances in iron and B vitamin metabolism, though causality remains to be established.
Clinical Implications
Monitoring hemoglobin levels may help identify individuals at increased risk for dementia, particularly when levels fall below 14 g/dL. Addressing anemia and its underlying causes, including nutritional deficiencies, could represent a modifiable target to reduce dementia incidence. Further research is needed to clarify mechanisms and to develop effective interventions.
Conclusion
Anemia is a significant, potentially modifiable risk factor for dementia, with evidence linking low hemoglobin to neurodegenerative pathology. Understanding and targeting anemia may enhance dementia prevention strategies globally.
References
Valletta et al 2023 -- Anemia and Dementia Risk in the SNAC-K Cohort
Lassen 1959 -- Cerebral Autoregulation in Anemia and Polycythemia
Additional population-based cohort studies 2020s -- Hemoglobin and Dementia Risk
